Concepedia

Weiwei Li

WL

Statistics

Publications

17

Citations

681

H-Index

14

Active since

1997

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Sun Yat-sen University

Rutgers Cancer Institute

First Affiliated Hospital of Xinxiang Medical University

Cornell University

Weiwei Li is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and life sciences.

Publications per year

1997–2024

17

Publications

17

A Functional Proteomic Strategy to Discover Inhibitors for Uncharacterized Hydrolases

Weiwei Li, Jacqueline L. Blankman, Benjamin F. Cravatt · Journal of the American Chemical Society · 2007 · 184 citations

Life Sciences, Biochemistry, Pharmacology +13

Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: identification of ecteinascidin-743 as a potent cytotoxic agent.

Weiwei Li, Naoto Takahashi, S.C. Jhanwar et al. · PubMed · 2001 · 93 citations

Medicine, Oncology, Pharmacology +12

The Multifunctional Ca2+/Calmodulin-dependent Kinase II δ (CaMKIIδ) Controls Neointima Formation after Carotid Ligation and Vascular Smooth Muscle Cell Proliferation through Cell Cycle Regulation by p21

Weiwei Li, Hui Li, Philip N. Sanders et al. · Journal of Biological Chemistry · 2010 · 60 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells.

Weiwei Li, Jian‐Gao Fan, Daniel Hochhauser et al. · PubMed · 1997 · 44 citations

Medicine, Cancer Biology, Oncology +17

Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes

Hui Zhang, Xuanxuan Jing, Xiaojuan Wu et al. · Anti-Cancer Drugs · 2015 · 43 citations

Medicine, Oncology, Pharmacology +15

1–5 of 17